Vicki Moore, PhD

Contributing Writer https://www.infectiousdiseaseadvisor.com

Vicki Moore, PhD, is a freelance medical writer for Hematology Advisor. Vicki received her PhD in biology from Arizona State University, where her research emphasized molecular biology, biochemistry, and metabolic engineering. She also has experience with predictive analytics and is intrigued by its applications to medicine. Vicki has been a medical writer, focusing on areas of hematology and oncology, among other specialties, since late 2017. You can find her on Linkedin at linkedin.com/in/vicki-moore-93950913

All articles by Vicki Moore, PhD

General Medicine

Increased Uptake of HPV Vaccine Projected to Reduce Oropharyngeal Cancer Incidence Over 25 Years

Vicki Moore, PhD

November 12, 2021

A new study projects that increasing HPV vaccination rates will trend toward reduced incidence of oropharyngeal cancer among younger adults until 2045.

A common antibiotic may be part of the key to fighting pancreatic cancer.

General Infectious Disease

Study Explores Effects of Antibiotic Use on Efficacy of Immune Checkpoint Inhibitor Therapy

Vicki Moore, PhD

July 15, 2021

Researchers sought to determine the effect of antibiotic use on efficacy of immune checkpoint inhibitor therapy during the 12 weeks before and after initiation of therapy.

COVID19

Immune Responses to COVID-19 in Patients With Hematologic Malignancies

Vicki Moore, PhD

April 21, 2021

A new study reveals a protective role for CD8 T-cell responses in cases of B-cell depletion in patients with COVID-19 and hematologic malignancies.

COVID19

Serum Antiphospholipid, Phospholipid-Binding Protein Antibodies in Coronavirus Disease 2019

Vicki Moore, PhD

December 7, 2020

Prothrombotic autoantibodies, similar to those with antiphospholipid syndrome, appear to be elevated in hospitalized patients with COVID-19.

COVID19

Venous Thromboembolism Rates in Patients With SARS-CoV-2 Infection

Vicki Moore, PhD

December 1, 2020

In a new study, researchers reported on the frequency of VTE among more than 6000 patients who tested positive for infection with SARS-CoV-2.

Emerging Diseases

Extracellular Histones in Cerebral Malaria Linked to Blood-Brain Barrier Breakdown

Vicki Moore, PhD

July 21, 2020

Surface accumulation of parasite histones may be linked to coagulation activation and blood-brain barrier breakdown in children with cerebral malaria.

Prevention

Coagulation Disorders and Bleeding Risks With Cefoperazone-Sulbactam

Vicki Moore, PhD

February 18, 2020

Of patients who received cefoperazone-sulbactam, 9.2% reported a coagulation disorder and 15.7% reported a decrease in platelet count.

Next post in Prevention